Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

BACKGROUND: Several drugs are available to treat metastatic renal-cell carcinoma (MRCC), and predictive markers to identify the most adequate treatment for each patient are needed. Our objective was to identify potential predictive markers of sunitinib activity in MRCC. METHODS: We collected sequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Gracia, J L, Prior, C, Guillén-Grima, F, Segura, V, Gonzalez, A, Panizo, A, Melero, I, Grande-Pulido, E, Gurpide, A, Gil-Bazo, I, Calvo, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788252/
https://www.ncbi.nlm.nih.gov/pubmed/19904265
http://dx.doi.org/10.1038/sj.bjc.6605409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788252/
https://www.ncbi.nlm.nih.gov/pubmed/19904265
http://dx.doi.org/10.1038/sj.bjc.6605409

Ejemplares similares